Aleta Biotherapeutics, Inc. — Form D

Aleta Biotherapeutics, Inc. of NATICK, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-16. $13.7M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-07-16
• Form: D
• Accession: 0001873000-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Amount sold: $13.7M
• Investors: 6
• Date of first sale: 2021-06-30
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-406597

Issuer

• Name: Aleta Biotherapeutics, Inc.
• CIK: 0001873000
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 27 STRATHMORE ROAD, NATICK, MA, 01760
• Phone: 508-282-6370

Officers, directors & promoters (1)

More

• CIK 1873000 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search